RT Journal Article
SR Electronic
T1 Polygenic risk score-based phenome-wide association study identifies novel associations for Tourette syndrome
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.01.22279340
DO 10.1101/2022.09.01.22279340
A1 Pritesh Jain
A1 Tyne Miller-Fleming
A1 Apostolia Topaloudi
A1 Dongmei Yu
A1 Petros Drineas
A1 Marianthi Georgitsi
A1 Zhiyu Yang
A1 Renata Rizzo
A1 Kirsten R. Müller-Vahl
A1 Zeynep Tumer
A1 Nanette Mol Debes
A1 Andreas Hartmann
A1 Christel Depienne
A1 Yulia Worbe
A1 Pablo Mir
A1 Danielle C. Cath
A1 Dorret I. Boomsma
A1 Veit Roessner
A1 Tomasz Wolanczyk
A1 Piotr Janik
A1 Natalia Szejko
A1 Cezary Zekanowski
A1 Csaba Barta
A1 Zsofia Nemoda
A1 Zsanett Tarnok
A1 Joseph D. Buxbaum
A1 Dorothy Grice
A1 Jeffrey Glennon
A1 Hreinn Stefansson
A1 Bastian Hengerer
A1 Noa Benaroya-Milshtein
A1 Francesco Cardona
A1 Tammy Hedderly
A1 Isobel Heyman
A1 Chaim Huyser
A1 Astrid Morer
A1 Norbert Mueller
A1 Alexander Munchau
A1 Kerstin J Plessen
A1 Cesare Porcelli
A1 Susanne Walitza
A1 Anette Schrag
A1 Davide Martino
A1 The EMTICS collaborative group
A1 Andrea Dietrich
A1 The TS-EUROGRAIN Network
A1 Carol A. Mathews
A1 Jeremiah M. Scharf
A1 Pieter J. Hoekstra
A1 Lea K. Davis
A1 Peristera Paschou
YR 2022
UL http://medrxiv.org/content/early/2022/09/02/2022.09.01.22279340.abstract
AB Tourette Syndrome (TS) is a complex neurodevelopmental disorder characterized by vocal and motor tics lasting more than a year. It is highly polygenic in nature with both rare and common previously associated variants. Epidemiological studies have shown TS to be correlated with other phenotypes, but large-scale phenome wide analyses in biobank level data have not been performed to date. In this study, we used the summary statistics from the latest meta-analysis of TS to calculate the polygenic risk score (PRS) of individuals in the UK Biobank data and applied a Phenome Wide Association Study (PheWAS) approach to determine the association of disease risk with a wide range of phenotypes. A total of 57 traits were found to be significantly associated with TS polygenic risk, including multiple psychosocial factors and mental health conditions such as anxiety disorder and depression. Additional associations were observed with complex non-psychiatric disorders such as Type 2 diabetes, heart palpitations, and respiratory conditions. Cross-disorder comparisons of phenotypic associations with genetic risk for other childhood-onset disorders (e.g.: attention deficit hyperactivity disorder [ADHD], autism spectrum disorder [ASD], and obsessive-compulsive disorder [OCD]) indicated an overlap in associations between TS and these disorders. ADHD and ASD had a similar direction of effect with TS while OCD had an opposite direction of effect for all traits except mental health factors. Sex-specific PheWAS analysis identified differences in the associations with TS genetic risk between males and females. Type 2 diabetes and heart palpitations were significantly associated with TS risk in males but not in females, whereas diseases of the respiratory system were associated with TS risk in females but not in males. This analysis provides further evidence of shared genetic and phenotypic architecture of different complex disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by NIH grants R01NS105746, R01MH126213 and NSF grants 1715202, and 2006929. ZT was supported by Lundbeck Foundation (R100-A9332). YW was funded by the Deutsche Forschungsgemeinschaft. DB was supported by KNAW Academy Professor Award (PAH/6635). PJ and CZ were funded by the National Science Center, Poland: UMO-2016/23/B/NZ2/03030. BH is an employee of Boehringer Ingelheim Pharma. AS received support from the NIHR UCL/H Biomedical Research Centre. CM is supported by NIH grants (R01NS105746; R01NS102371)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research has been conducted using the UK Biobank Resource under the application number 61553I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.